Clinical Trial Update: Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body [Phase 1]

View source ↗

Summary

Phase 1 bioequivalence study of imatinib mesylate capsule in chronic myeloid leukemia; results were posted on 2015-05-19.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Imatinib mesylate capsule (imatinib mesylate)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2015-05-19